Health In Tech, Inc. (HIT) stock

HITNasdaqInsurance Agents, Brokers & ServiceFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30

$0.40−0.14 (-26.12%)

Close on Nov 13, 2026Market cap $25.92MP/E –Yield –

Health In Tech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Health In Tech's price to sales ratio was 1.0× on Nov 11, 2026, against 2.9× a year earlier.

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	1.0×	−2.0
2025	Dec 31, 2025	3.0×	–

Parsed from the XBRL in Health In Tech's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is HIT.

Revenue growth0.7% · median 8.5%

Gross margin50.5% · median 48.8%

Net margin-37.1% · median -21.0%

Advertisement
300 × 250

See a number that looks wrong?